The FDA has expanded Dupixent's use to additional pediatric patients while continuing to review reports of cutaneous T-cell lymphoma. Researchers, regulators, and attorneys are closely watching developments involving the widely prescribed medication.
New Joint Commission data shows hospital patient falls reached an all-time high in 2024. Learn why these injuries continue to rise, what reporting changes are coming in 2027, and when a preventable hospital fall may support a medical malpractice claim.
Anesthesia errors can lead to devastating injuries, including brain damage, paralysis, and death. Learn how these mistakes happen, when they may constitute medical malpractice, and what Virginia patients and families should know after a preventable anesthesia injury.
Bayer’s proposed $7.25 billion settlement is facing official opposition from Roundup cancer victims and their attorneys. They claim the deal benefits the manufacturer and plaintiffs' lawyers more than people diagnosed with non-Hodgkin lymphoma after using the weedkiller.
The husband of a woman who died from complications of gastroparesis allegedly caused by Ozempic has filed a lawsuit against Novo Nordisk, the drug manufacturer. At the same time, the GLP-1 weight loss drug multidistrict litigation (MDL) has grown to include over 3,600 lawsuits.
Between February 2026 and May 2026, more than 1,600 lawsuits were filed in the federal birth control tumor MDL, bringing the total to nearly 3,800. It’s one of the fastest growing mass torts in the U.S., and new filings allege Pfizer knew of the risk of meningiomas as far back as 1983.
A $7.25B deal promises payouts for Roundup cancer victims, but tiered compensation, denied claims, and lower payouts versus jury verdicts raise serious fairness concerns for thousands of cancer plaintiffs.
What’s really in infant formula? New FDA testing provides answers while raising broader questions about safety, transparency, and ongoing NEC lawsuits tied to premature infant care.
Direct-to-consumer drug ads influence patient choices, prescribing patterns, and healthcare costs. Learn how marketing shapes decisions and raises legal concerns.
Kratom poisonings continue to rise nationwide, with most deaths tied to multiple substances. Months after Louisiana’s ban, new questions are emerging about its impact and ongoing risks.
Recent progress has been made in the paraquat Parkinson's MDL. Combined with additional evidence supporting allegations the herbicide causes Parkinson's disease and links to other health risks indicates 6,500 cases may be closer to a resolution. Analysts estimate settlements will be substantial.
AI can offer quick answers to health questions, but what happens when it gets it wrong? Concerns are growing about misdiagnosis, delayed care, and who may be responsible when AI medical advice leads to harm.
